Fungal periprosthetic joint infection of the hip: a systematic review

Benjamin Schoof1, Oliver Jakobs1, Stefan Schmidl1

  • 1Department of Orthopedic Surgery, HELIOS Endo-Clinic Hamburg , Hamburg, Germany.

Orthopedic Reviews
|April 16, 2015
PubMed

Insights

Fungal periprosthetic joint infection (PJI) after hip replacement is challenging to treat. A review of 45 cases suggests a two-stage revision is favorable, but guidelines are needed for fungal PJI management.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Medical Mycology

Background:

  • Periprosthetic joint infection (PJI) is a serious complication following total joint arthroplasty, occurring in approximately 1% of cases.
  • Fungal PJI presents unique challenges due to the high risk of persistent infection and limited treatment options.

Purpose of the Study:

  • To investigate the current management strategies for fungal PJI specifically in total hip arthroplasty.
  • To systematically review published cases to identify effective treatments and areas for improvement.

Main Methods:

  • A systematic literature review was conducted.
  • Analysis included 45 reported cases of fungal PJI in total hip arthroplasty.

Main Results:

  • The two-stage revision procedure is currently the favored approach for managing fungal PJI of the hip.
  • There is ongoing debate regarding the efficacy of antifungal drug-loaded cement spacers in treating these infections.

Conclusions:

  • Experience with fungal PJI in total hip arthroplasty is limited, highlighting a critical need for established treatment guidelines.
  • Further research and data collection are essential to optimize the medical management of fungal periprosthetic hip infections.

Related Concept Videos